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PObjective: Surgical results have shown the superiority of human heart valve and vas-
cular allografts over artificial prostheses when used for the treatment of infectious car-
diovascular diseases. However, the mechanism of infection resistance in these
allografts has not been determined. In this study the contribution of the inflammatory
response after allogeneic transplantation to the antimicrobial mechanism was as-
sessed, focusing on the induction of indoleamine 2,3-dioxygenase, a tryptophan-
metabolizing enzyme.
Methods:Aortic transplantation was performed with inbred rats, and aortic allografts,
isografts, and control grafts were obtained for the following analyses. The extent of
inflammatory-related and indoleamine 2,3-dioxygenase gene expression was mea-
sured by means of quantitative reverse transcriptase–polymerase chain reaction,
and tryptophan metabolite production in the graft was measured by means of liquid
chromatographic/tandem mass spectrometric analysis. The bacteriostatic effect of
each graft and tryptophan metabolites was determined by using the methicillin-resis-
tant Staphylococcus aureus proliferation assay.
Results: The inflammatory response, including interferon g, tumor necrosis factor a,
and indoleamine 2,3-dioxygenase gene expression, was significant in the allografts
but minimal in the isografts and control grafts. Methicillin-resistant S aureus prolifer-
ation was remarkably suppressed when cultured with the allografts but not with the
control grafts. Among tryptophan metabolites, the bacteriostatic effect against meth-
icillin-resistant S aureuswas remarkable with 3-hydroxykynurenine, with a minimum
inhibitory concentration of 32 mg/L. The 3-hydroxykynurenine level in the allografts
was 9-fold greater than that in the control grafts.
Conclusion: The bacteriostatic effect of the allografts was acquired by inducing indo-
leamine 2,3-dioxygenase, which resulted in local production of 3-hydroxykynurenine
as an antimicrobial agent. This is the first report to document a mechanism of the
allograft’s infection-resistant property against methicillin-resistant S aureus growth.
L
ocally advanced prosthetic aortic valve endocarditis often results in a poor
clinical outcome with short-term mortality rates of 8% to 39%,1-5 despite re-
cent progress in antimicrobial therapy and surgical techniques. Gram-positive
cocci, such as Staphylococcus aureus, are frequently isolated, and among these, meth-
icillin-resistant S aureus (MRSA) bacteremia is associated with significantly higher
mortality rates than other microbes.
Surgical procedures for infective endocarditis treatment usually involve complete
resection of the infected area and reconstruction of the defect with valvular prostheses,
including mechanical valves, bioprosthetic valves, or allograft heart valves known as
homografts. The purported benefits of using homografts are that they do not require
adjuvant systemic anticoagulation therapy or immunosuppressive therapy and that
they might provide a better clinical outcome for infective cardiovascular disease
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CSPAbbreviations and Acronyms
BN 5 Brown Norway
3-HAA 5 3-hydroxyanthranilic acid
3-HK 5 3-hydroxykynurenine
IDO 5 indoleamine-2,3-dioxygenase
IFN 5 interferon
Kyn 5 kynurenine
LC-MS/MS 5 liquid chromatography/tandem mass
spectrometry
LEW 5 Lewis
MH 5 Mueller–Hinton
MRSA 5 methicillin-resistant Staphylococcus aureus
PCR 5 polymerase chain reaction
POD 5 postoperative day
QA 5 quinolinic acid
TNF 5 tumor necrosis factor
Trp 5 tryptophan
compared with prosthetic devices. Since the 1990s, some ret-
rospective case series have indicated the possible superiority
of homograft use for severe infective endocarditis and pros-
thetic valve endocarditis cases.6-11 However, there is no
firm consensus of the homografts’ potential for antimicrobial
capacity because of the absence of randomized controlled
studies and scientific evidence supporting this mecha-
nism.12,13
Indoleamine 2,3-dioxygenase (IDO) is an interferon
(IFN) g–induced, rate-limiting enzyme of the L-tryptophan
(Trp)–L-kynurenine (Kyn) pathway.14,15 IDO is known as
one of the most important factors to induce immunologic tol-
erance by suppressing T-cell proliferation through Trp de-
generation and by producing toxic Trp metabolites.16 On
the other hand, IDO is also known to play a crucial role in
mitigating microbial infection by toxic Trp metabolites.17,18
Because heart valves and vascular allografts do not usually
require blood type or HLA (human leukocyte antigen) type
matching between donor and recipient and yet for the most
part they survive immunologic attack without adjuvant im-
munosuppressive therapy, one possible mechanism linking
both antimicrobial activity and possible immune tolerance
of allografts is the contribution of IDO. In this study we ex-
amined how allogeneic vascular grafts resist MRSA infection
using a rat subrenal aortic transplantation model. We partic-
ularly focused on the role of IDO as a potential contributor to
the allograft’s antimicrobial activity.
Materials and Methods
Experimental Model
Rat in situ vascular allograft transplantation was carried out in the
infrarenal position (ie, the infrarenal model). After intraperitoneal
injection of pentobarbital (5 mg/100 g of body weight), segments
of descending thoracic aorta were harvested from Lewis (LEW)
rats (RT1A1B1 Charles River Japan, Inc, Yokohama, Japan) and160 The Journal of Thoracic and Cardiovascular Surgery c Julimmediately transplanted to either LEW or Brown Norway (BN)
rats (RT1AnBn) after achievement of pentobarbital-induced anesthe-
sia. In the infrarenal model the aortic anastomosis was carried out
through a midline laparotomy, and a 1-cm segment graft was anas-
tomosed to the recipient aorta between the renal artery and the
terminal aorta in end-to-end fashion with 9-0 nylon interrupted
sutures (Bear, Chiba, Japan). In each experiment 4 to 6 rats from
each group were sacrificed by means of exsanguination at postoper-
ative days (PODs) 7 or 28, and the grafts were explanted for analysis.
Alternatively, aortic graft transplantation to a ventral subcutaneous
pocket was applied, and the POD28 samples were obtained. This
subcutaneous model is widely accepted as an ectopic transplantation
model19 and is also effective in minimizing animal use. No anticoag-
ulants, immunosuppressants, or antibiotics were administered at any
time intraoperatively or postoperatively. Initially, grafts from the in-
frarenal model were used for analysis, including detection of gene
expression and the antimicrobial determination assay, because the
in situ model was thought to well reflect the clinical use of the allo-
graft. After we confirmed that the grafts obtained from either trans-
plantation model were similar in terms of gene expression pattern
and performance against MRSA growth, grafts from the subcutane-
ous model were used for the rest of the analyses.
In our experiments isograft refers to the explanted grafts ob-
tained from the donor-LEW, recipient-LEW combinations, whereas
allograft refers to explanted grafts obtained from donor- LEW, re-
cipient-BN combinations. For the control graft, naive LEW thoracic
aortas were used. The experimental protocol was approved by the
institutional board of animal care (approval no. 1516T055), and han-
dling and care of the animals were carried out based on the regula-
tions of the Laboratory Animal Center for Experimental Research
and the ‘‘Guide for the care and use of laboratory animals’’ prepared
by the Institute of Health (National Institute of Health publication
no. 85-23, revised in 1985).
Determination of Antibacterial Activity
MRSA N315 was used for the determination of antibacterial activ-
ity.20 Allografts obtained from both the subrenal group and the sub-
cutaneous group and control grafts were submitted for analysis.
MRSA suspension was prepared with a fresh single colony and sa-
line water. Colony-forming units were calculated by means of the
plating of serially diluted bacteria on mannitol salt agar (Eiken
Chemical, Tokyo, Japan). The explanted grafts were transferred in
60 mL of a 2-fold concentration of Mueller–Hinton (MH) broth (Ox-
oid, Hampshire, England) and incubated for 12 hours at 35C for ex-
traction of antibacterial agents from grafts. After centrifugation at
15,000 rpm for 2 minutes, the supernatant was collected and boiled
for 2 minutes. The collected supernatant was used as32 culture me-
dium for determination of antibacterial activity of the grafts. MRSA
solution (approximately 50 colony-forming units of bacteria/10 mL)
and distilled water (40 mL) with or without Trp metabolite was
added into the 32 culture medium or 32 MH medium (50 mL).
The bacterial mixture (100 mL) was incubated at 35C. Five micro-
liters of the culture was picked every hour and transferred into 95 mL
of MH broth. Immediately, 50 mL of the diluted culture was spread
onto mannitol salt agar. After incubation for 12 hours at 35C, the
colony grown on the plate was counted. Bacterial growth in the pres-
ence of Trp metabolites was determined by the measure of the opti-
cal density at 600 nm with the microplate photometer SAFIRE
(TECAN, Mannedorf, Switzerland).y 2008
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PRNA Isolation and Real-time Polymerase
Chain Reaction
RNA isolation and real-time polymerase chain reaction (PCR) were
performed as previously described.21 Total RNAwas extracted from
tissues with TRIzol reagent (Invitrogen Corp, Carlsbad, Calif), and
cDNA was synthesized by a Superscript II Reverse Transcriptase
(Invitrogen Corp) by using 2 mg of total RNA treated with DNase
I (Invitrogen Corp), both according to the manufacturer’s instruc-
tions. The reaction solution was subjected to real-time PCR reac-
tions on the Mx3000 real-time PCR system (Stratagene, La
Jolla, Calif) for 40 cycles. The PCR condition of each target gene
is described in Table 1. Taq Antibody (TAKARA Bio, Inc, Shiga,
Japan) or Betaine Monohydrate (Sigma-Aldrich Corp, St Louis,
Mo) were occasionally added to the PCR reaction solution, as appro-
priate, to obtain better-quality PCR results.22 Emitted fluorescence
of SYBR Green (Sigma-Aldrich) for each reaction was measured
during the extension phase, and the number of copies was quantified
by comparison with standard plasmid obtained by mens of TA clon-
ing (Topo Cloning Kit, Invitrogen Corp). The calculated number of
copies was divided by the number of copies of b-actin and amplified
1000 times for convenience.
Immunohistochemistry
Four-micrometer-thick frozen sections were fixed for 5 minutes with
10% neutral buffered formalin. The sections were blocked with
0.5% goat serum, along with avidin/biotin blocking (Avidin/Biotin
Blocking kit; Vector Laboratories, Inc, Burlingame, Calif) before
the addition of a primary antibody, per the manufacturer’s instruc-
tions. The sections were incubated overnight at 4C with goat poly-
clonal antibody anti-IDO (1:100, Santa Cruz Technology, Santa
Cruz, Calif) diluted in 1% bovine serum albumin. The sections
were then reacted with biotinylated anti-rabbit immunoglobulins
(1:1000; DAKO, Glostrup, Denmark) for 1 hour at room tempera-
ture, followed by incubation with Avidin-Biotinylated enzyme
Complex (VECTASTAIN ABC-AP mix; Vector Laboratories,
Inc) for 1 hour at room temperature. The immunocomplex was visu-
alized as a brown product after incubating with diaminobenzidine,
and counterstaining was done with hematoxylin.
Liquid Chromatographic/Tandem Mass
Spectrometric Analysis
The subcutaneous model grafts were homogenized in distilled wa-
ter, with a final concentration of 8% to 10%. Each homogenate
was diluted to a concentration of 5%. These were centrifuged for
15 minutes at 13,000 rpm at room temperature, and supernatants
were filtered with Ultrafilter (Cosmospin Filter H, 0.45 mm; Nacalai
TABLE 1. Concentration of Kyn, 3-HK, and 3-HAA in the
tissue
Control graft (ng/mg) Allograft (ng/mg) P value
Kyn 2.16 6 0.61 3.88 6 2.17 ND
3-HK 1.67 6 1.22 15.7 6 5.11 ,.005
3-HAA 0.37 6 0.12 0.60 6 0.09 ,.05
Kyn, Kynurenine; 3-HK, 3-hydroxykynurenine; 3-HAA, 3-hydroxyanthoranilic
acid; ND, not done.The Journal of ThorTesque, Inc, Kyoto, Japan). After centrifugation, each 180 mL of su-
pernatant was mixed with 10 mL of water and the internal standard,
200 ng/mL d-biotin. A 10-mL sample preparation was injected for
liquid chromatographic/tandem mass spectrometric (LC-MS/MS)
analysis. Samples were analyzed by using a hybrid triple quadrupole
linear ion-trap API 4000 QTRAP LC-MS/MS system (Applied Bio-
systems, Inc, Foster City, Calif) with an Agilent 1100 series high-
performance liquid chromatography (Agilent Technologies, Inc,
Palo Alto, Calif). All spectra were acquired in positive ion mode.
The liquid chromatograph was equipped with an Atlantis C18 col-
umn (2.1 3 50 mm, 3-mm particle size; Water Corp, Lowell,
Mass), and eluents used were as follows: A, 0.025mol/L ammonium
acetate; B, acetonitrile (40:60). The flow rate was set to 300 mL/min.
The ion source was operated in the positive ion mode by using
electrospray ionization Turbo Spray at 700C, and analyses
were performed by using enhanced product ion scanning and the
multiple-reaction monitoring mode. Signals of characteristic ions
for each Trp metabolite and the internal standard (d-biotin) were
described as follows: Kyn (209.00/ 94.00), 3-hydroxykynurenine
(3-HK; 225.10 / 110.20), 3-hydroxyanthranilic acid (3-HAA;
154.10/ 80.10), and d-biotin (245.15/ 97.00). Collision ener-
gies were optimized as 39 eV for Kyn, 23 eV for 3-HK, and 39
eV for 3-HAA, respectively.
Statistical Analysis
Results were presented as means 6 standard error of the mean.
Comparisons were made by using the Student t test or analysis of
variance with the Bonferroni/Dunn post-hoc test, as appropriate.
Results
MRSA Growth Suppression
Initially, we transplanted LEW rat thoracic aortas into BN rats
using both the infrarenal and subcutaneus models. The grafts
were explanted at POD28 and submitted to the antimicrobial
determination assay by usingMRSA, in which the grafts were
incubated in MH broth and the supernatant of the broth was
applied to cultivation of MRSA on mannitol salt agar to esti-
mate the extent of MRSA proliferation. Bacterial growth was
determined based on the optical density at 600 nm for quan-
tification. No MRSA proliferation was observed for the first
7 hours in all the assays, including the infrarenal allograft,
subcutaneus allograft, and control graft (naive LEWaorta) as-
says (Figure 1, A). The proliferation curve for control grafts
started to steeply rise after 7 hours of cultivation, whereas
the proliferation curve for the allografts still showed very
low proliferation. At the end of the assay, after 10 hours of
cultivation, MRSA colony count was 59,360.0 6 11,622.0
for the control graft assay, whereas it was 20,146.7 6
2417.4 for the infrarenal allograft assay and 15,686.7 6
2523.5 for the subcutaneous allograft assay (P , .01 for
both allograft groups vs the control group). The extent of
MRSA growth suppression in the infrarenal allograft and
the subcutaneous allograft was not statistically different.
The difference in MRSA proliferation between the allograft
assay and control graft assay could be visualized by the num-
ber of colonies on the mannitol salt agar (Figure 1,B). The topacic and Cardiovascular Surgery c Volume 136, Number 1 161
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CSP2 plates of Figure 1, B, demonstrate the results of the infrare-
nal allograft assay, and the lower 2 plates show the results of
the control graft assay (left, 8 hours of cultivation; right, 9
hours of cultivation). In summary, these series of assays re-
vealed that the rat aortic grafts acquired antimicrobial activity
to MRSA after allogeneic transplantation. We also showed
that the allograft after infrarenal transplantation and subcuta-
neus transplantation did not differ in antimicrobial activity.
Figure 1. Antimicrobial activity of the allografts and control grafts
against methicillin-resistant Staphylococcus aureus (MRSA) pro-
liferation in vitro. The allografts were obtained from either the in-
frarenal or subcutaneous model at postoperative day 28. The
explanted grafts and control grafts were submitted to Mueller–
Hinton broth, respectively, and the suspension was applied to
mannitol salt agar every hour to estimate the difference in
MRSA proliferation. A, MRSA colony count is expressed in the
graph by time course. MRSA proliferation was remarkable when
cultured with control grafts (open circles), whereas allografts ob-
tained by means of subdermal (open squares) or infrarenal (open
diamonds) transplantation presented MRSA growth suppression.
B, MRSA proliferation was visualized on the mannitol salt agar
8 hours (left) and 9 hours (right) after incubation. The MRSA pro-
liferation was remarkably suppressed for allografts compared
with that seen in control grafts.162 The Journal of Thoracic and Cardiovascular Surgery c JuIn the next series of experiments, we examined induction
of the inflammatory response followed by IDO expression as
a possible contributor to the antimicrobial activity presented
by allografts.
Inflammatory Cytokines and IDO Induction After
Allogeneic Transplantation
In this section we tried to verify the induction of a specific
inflammatory response after allograft transplantation through
IDO expression, which we hypothesized is a key factor for
antimicrobial activity of the allografts. To that end, we as-
sessed gene expression for tumor necrosis factor (TNF) a,
IFN-g, and IDO in the explanted grafts. Gene expression
in the isografts was assessed for comparison to estimate
the extent of non-specific surgical manipulation–derived in-
flammatory response. By using the infrarenal transplantation
model, the isografts and the allografts obtained at POD7 and
POD28 were submitted to quantitative reverse transcriptase–
PCR for analysis together with the control grafts (Figure 2,
A). TNF-a gene expression was remarkably increased in
the allografts, whereas isografts showed significantly lower
gene expression, and the level in the allografts was 6-fold
greater than that in the isografts at POD28. For IFN-g
gene expression, gene expression also increased in the allo-
grafts, and the expression level was 20-fold greater in the al-
lografts than in the isografts at POD28 (Figure 2, B). IDO,
expressed downstream of IFN-g gene expression, was also
remarkably increased in the allografts, and its level at
POD28 was almost 60-fold greater in the allografts than in
the isografts (Figure 2, C). In the control grafts all of the tar-
get genes (TNF-a, IFN-g, and IDO) were detected at very
low levels, and there was no statistical difference for each
gene expression between control grafts and isografts at any
time point. The inflammatory response and IDO expression
in the allografts was also confirmed by means of histopatho-
logic examination (Figure 3). Hematoxylin and eosin stain-
ing of the explanted allograft revealed gross inflammatory
cell infiltration in the adventitia and occasionally in the in-
tima (Figure 3, B). IDO was detected by means of immuno-
histochemical staining in the same distribution as the
inflammatory cells in the intima and the adventitia (Figure 3,
C). These results showed that a specific inflammatory re-
sponse was induced within the grafts accompanying IDO
gene and protein expression, suggesting that IDO partici-
pates in the allograft’s antimicrobial activity at the site of
allogeneic transplantation.
MRSA Proliferation Suppression by the Trp
Metabolites
In the previous sections we observed that rat aortic allografts
acquired antimicrobial activity through allogeneic transplan-
tation and that the allografts presented IDO gene and protein
expression after IFN-g induction. Because IDO expression
has been viewed as crucial for regulating inflammatoryly 2008
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Figure 2. Results of mRNA expression for tumor necrosis factor
(TNF) a (A), interferon (IFN) g (B), and indoleamine-2,3-dioxyge-
nase (IDO; C) in the explanted grafts by means of quantitative re-
verse transcriptase–polymerase chain reaction. The expression
level was compared between control grafts (ctrl, small dot bar),
allografts (closed bar), and isografts (open bar) at postoperative
days (POD) 7 and 28, and the control grafts (without transplanta-
tion manipulation) were also examined. TNF-a and IFN-g levels
increased over time in the allografts, and the difference betweenThe Journal of Thorresponse through toxic metabolites of Trp,17,18 we investi-
gated the antimicrobial activity of Trp and its major metabo-
lites against MRSA proliferation. The metabolites included
Kyn, 3-HK, anthoranilic acid, 3-HAA, and quinolinic acid
(QA). These substances were prepared in series of concentra-
tions of 256, 32, and 8 mg/mL.
The results from these series of assays are shown in Fig-
ure 4. MRSA started proliferating after 10 hours of cultiva-
tion under the appearance of Trp at any concentration, and
the same proliferation pattern was obtained from the assay
with Kyn (Figure 4, A and B). These results implied that
Trp and Kyn had no antimicrobial activity. From Figure 4,
C, MRSA growth suppression was clearly detected under
the influence of 3-HK at 256 and 32 mg/mL, which lasted
at least 18 hours after cultivation. The assay with anthoranilic
acid and 3-HAA also showed mild growth suppression only
at 256 mg/mL (Figure 4, D and E). QA also had just a mild
temporal effect (Figure 4, F). These series of results indicate
that some of the Trp metabolites are toxic to MRSA,
and among them, 3-HK has relatively strong antimicrobial
activity.
In all of the previous experiments, we have observed an-
timicrobial activity in the allografts and have confirmed
IDO expression in the allografts as a key factor of this antimi-
crobial activity. For a further understanding of this mecha-
nism, we investigated the influence of each Trp metabolite
on MRSA growth, which proved that 3-HK has moderate
bacteriotoxicity. The next issue to be clarified was whether
3-HK is actually produced at the site of allogeneic transplan-
tation.
Production of Trp Metabolites in the Grafts
In the next series of experiments, we investigated whether
IDO is active as an enzyme in the allografts, thus producing
3-HK, which has a bacteriotoxic effect against MRSA. The
homogenate of the allografts and control grafts was sub-
jected to LC-MS/MS analysis for detection and quantifica-
tion of Kyn, 3-HK, and 3-HAA within the graft tissue.
The quantification was performed by calculating in compar-
ison to the standard area for 10 ng/mg of each substance.
The results for Kyn can be seen in the top 3 graphs of Fig-
ure 5, A, with the standard area curve on the left, control in
the middle, and allograft on the right. The peak area for
Kyn in the allograft tissue was greater than that in the con-
trol graft tissue, as was the peak area for 3-HAA (Figure 5,
C). The peak area for 3-HK, the key substance among the
Trp metabolites, was also detected in the allograft tissue,
and its level was significantly greater in the allograft tissue
than in the control tissue (Figure 5, B). The calculated
the allografts and isografts was remarkable at POD28. IDO expres-
sion became apparent in the allografts at POD7, whereas almost
no expression was observed in the isografts. *P < .05.acic and Cardiovascular Surgery c Volume 136, Number 1 163
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CSPFigure 3. Histologic detection of inflammatory changes and IDO expression in the allograft. A, Control; B, hematox-
ylin and eosin stain; C, immunohistochemical staining for indoleamine-2,3-dioxygenase (IDO). There was a remark-
able inflammatory cell infiltration in the intima and adventitia (B), where IDO was widely expressed. Bars indicate
50 mm. DAB, Diaminobenzidine.amount of each substance is shown in Table 1. The allograft
tissue contained approximately 9 times greater 3-HK levels
than the control tissue versus 1.5 times for 3-HAA and al-
most the same amount for Kyn. Therefore 3-HK was actu-
ally produced in the allografts in much greater levels than in
the control grafts, suggesting that IDO induction, along
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Figure 4. Antimicrobial activity of tryp-
tophan (Trp; Panel A) and its metabolite
against methicillin-resistant Staphylo-
coccus aureus (MRSA) at different
concentrations (256 mg/mL, closed cir-
cles; 32 mg/mL, closed squares; 8 mg/
mL, closed triangles). Bacterial growth
was determined based on the optical
density (O.D.) at 600 nm by a using mi-
croplate photometer. Among those sub-
stances, 3-hydroxykynurenine (3-HK)
showed relatively strong suppression
on MRSA growth at a concentration of
32 mg/mL (C), and 3-hydroxyanthoranilic
acid (3-HAA; E) showed a very mild
antimicrobial effect at 256 mg/mL. Kyn
(Panel B), Kynurenine; 3-HK (Panel C),
3-Hydroxykynurenine; 3-HAA (Panel E),
3-Hydroxyanthoranilic acid; AA (Panel
D), anthoranilic acid; QA (Panel F), qui-
nolinic acid.
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PFigure 5. Kynurenine (Kyn), 3-hydroxykynurenine (3-HK), and 3-hydroxyanthoranilic acid (3-HAA) content in the
grafts by means of liquid chromatographic/tandem mass spectrometric (LC-MS/MS) analysis. The grafts, either ex-
planted or control, were homogenized in distilled water, and the supernatant was submitted to LC-MS/MS. By using
the standard curve, the content was quantified by measuring the identical peak area and calculating in accordance
with the standard curve. Among tryptophan (Trp) and its metabolites, 3-HK was detected in the grafts, with a signif-
icant difference found between the allografts and the control grafts (see also Table 1).with 3-HK production, could contribute to the allograft’s
tolerance against MRSA infection.
Discussion
The main findings of this study were that the animal tissue
can present antimicrobial activity against MRSA after allo-The Journal of Thogeneic transplantation in association with the production of
3-HK, a Trp metabolite by IDO. This concept could ex-
plain the clinically observed benefit of using human heart
valve and vascular allografts in patients with infective
endocarditis and infective aortic aneurysms, especially
MRSA-related infection; that organism is one of the mostracic and Cardiovascular Surgery c Volume 136, Number 1 165
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CSPproblematic bacteria involved in infective endocarditis and
prosthetic valve endocarditis in the clinical arena.
Our initial series of antimicrobial activity assays clearly
showed remarkable MRSA growth suppression in the allo-
grafts, and this was not observed in the control graft assays.
The MRSA assay that we adopted was our original model,
which allowed us to measure the extent of MRSA growth
under the influence of byproducts after allogeneic trans-
plantation in the exudate broth of the graft, which was sta-
ble against heat (data not shown). The fact that boiled
exudate maintained antimicrobial activity supports the
concept that the key element is a heat-stable non-protein
substance compatible with a Trp metabolite. To our knowl-
edge, our report is the first to prove that homologous grafts
acquire antimicrobial capacity through allogeneic transplan-
tation, where the influence of a specific inflammatory
response exists, through an IFN-g–mediated immunoregu-
lated response.
In this study we have drawn attention to IDO activity, de-
rived from the IFN-g–mediated specific immune response, as
a possible antimicrobial mechanism that could link to the im-
munogenicity of allografts. IDO has been recognized as a key
enzyme for regulating the inflammatory response at the site
of infection by producing toxic Trp metabolites and by con-
suming an indispensable structural component of microor-
ganisms.17,18,23-26 Because there has been no previous
report showing the direct antimicrobial effects of specific
Trp metabolites, we studied these substances in detail, focus-
ing on their effects againstMRSA.We observed a strong bac-
teriostatic effect of 3-HK, which was isolated from the
allograft by means of LC-MS/MS analysis. A recent report
has shown that Trp metabolites are effective in the treatment
of TH1-mediated autoimmune disease by inhibiting autoreac-
tive TH1 cells.
27 Other reports have also shown that 3-HK
and QA have neurotoxicity among the Kyn pathway, a major
Trp-metabolizing pathway led by IDO activity.28-30 This
neurotoxicity have been described partially as a result of con-
version of 3-HK and QA to reactive oxygen species that ini-
tiate apoptosis, an effect that would be reduced by radical
scavengers.29 The antimicrobial effect of 3-HK noted in
this study might be derived, in part, from the similar endog-
enous oxidative stress generation of 3-HK and QA.
Recent experiments on infection and IDO have shown that
the endogenous protection mechanism of living tissue can in-
duce IDO in the context of inflammatory response against in-
fectious stimuli, thus exhibitingantimicrobial activity.17,18,23-26
In the context of these previous reports, our experiments high-
light the underlying mechanism of allograft resistance to in-
fectious cardiovascular disease. Moreover, the benefit of
surgical treatment with allograft heart valves for severe infec-
tive endocarditis and prosthetic valve endocarditis of the aor-
tic root must include sufficient debridement and direct
irrigation of the infected area, the proper 3-dimensional recon-
struction of destructive lesions, and the prevention of local166 The Journal of Thoracic and Cardiovascular Surgery c Julybacterial growth by 3-HK, a key product of IDO activity trig-
gered by a local IFN-g–mediated immune response.
Nonetheless, these studies are still preliminary, and sev-
eral issues need to be clarified in the future. These include
convincingly proving the existence of IDO interference to
the allograft antimicrobial effect by applying an IDO inhibi-
tor (eg, 1-methyltryptophan) or using IDO knockout animals.
Additional experiments need to investigate the precise mech-
anisms of 3-HK, 3-HAA, and QA on the microorganisms and
to determine the magnitude of IDO’s role among all the pos-
sible anti-infectious factors. Furthermore, the use of tissue-
engineered autografts for infectious cardiovascular disease
should be investigated because these grafts also have the
potential of inducing IFN-g–related inflammation, with an
expectation of similar antimicrobial activity as seen in allo-
grafts. In addition to antimicrobial activity, IDO might
interfere with immunologic tolerance of homografts, and ex-
periments are underway in our laboratory to investigate this.
In summary, our results suggest that the induction of IDO
in the context of inflammatory responses to allogeneic trans-
plantation makes the allografts resistant to bacterial infection
by producing the toxic Trp metabolite 3-HK. Together with
the immunologic tolerance effect by IDO, it is likely that
the allogeneic immune response supports both of the benefi-
cial processes of the host/pathogen and host/graft interface by
inducing IDO in the allograft tissue. In addition, the agents
that can induce 3-HK might have potential therapeutic value.
We thank Professor Richard J. Novick for help with editorial
revisions.
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